Menu
GeneBe

MOCS2

molybdenum cofactor synthesis 2

Basic information

Region (hg38): 5:53095678-53110063

Links

ENSG00000164172NCBI:4338OMIM:603708HGNC:7193Uniprot:O96007, O96033AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type B (Moderate), mode of inheritance: AR
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type B (Strong), mode of inheritance: AR
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type B (Definitive), mode of inheritance: AR
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type B (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Molybdenum cofactor deficiency, type BARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic11746050; 16021469; 16429380; 19544009; 21031595

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MOCS2 gene.

  • not provided (234 variants)
  • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B (74 variants)
  • Platelet-type bleeding disorder 9 (11 variants)
  • Combined molybdoflavoprotein enzyme deficiency (8 variants)
  • Inborn genetic diseases (7 variants)
  • not specified (2 variants)
  • Abnormality of metabolism/homeostasis (1 variants)
  • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MOCS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
39
clinvar
40
missense
82
clinvar
13
clinvar
2
clinvar
97
nonsense
7
clinvar
1
clinvar
8
start loss
1
clinvar
2
clinvar
1
clinvar
4
frameshift
10
clinvar
3
clinvar
1
clinvar
14
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
4
clinvar
4
splice region
4
9
1
14
non coding
3
clinvar
31
clinvar
30
clinvar
24
clinvar
88
Total 18 13 116 83 26

Highest pathogenic variant AF is 0.000112

Variants in MOCS2

This is a list of pathogenic ClinVar variants found in the MOCS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-53095702-T-C Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Likely benign (Jan 13, 2018)907140
5-53095725-C-A Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 12, 2018)907141
5-53095927-T-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)907142
5-53095930-C-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)907143
5-53095951-C-A Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 13, 2018)907144
5-53095993-C-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 12, 2018)907145
5-53096020-T-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B • Platelet-type bleeding disorder 9 Benign (Jan 13, 2018)903786
5-53096187-G-A Platelet-type bleeding disorder 9 • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 13, 2018)903787
5-53096245-A-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Likely benign (Jan 13, 2018)903788
5-53096444-G-A Platelet-type bleeding disorder 9 • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 13, 2018)903789
5-53096557-C-T Platelet-type bleeding disorder 9 • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Conflicting classifications of pathogenicity (Jan 13, 2018)903790
5-53096570-C-T Platelet-type bleeding disorder 9 • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 13, 2018)905687
5-53096684-T-C Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Mar 16, 2018)905688
5-53096689-C-T Platelet-type bleeding disorder 9 • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign/Likely benign (Apr 01, 2023)905689
5-53096730-G-A Platelet-type bleeding disorder 9 • Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 13, 2018)905690
5-53096929-A-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 12, 2018)906212
5-53096944-C-T Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)906213
5-53097057-C-T Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)906214
5-53097058-G-T Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 12, 2018)906215
5-53097119-G-A Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)906216
5-53097178-C-T Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)907205
5-53097318-G-C Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)907206
5-53097435-C-T Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 12, 2018)907207
5-53097591-C-T Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Benign (Jan 13, 2018)907208
5-53097726-A-G Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Uncertain significance (Jan 13, 2018)907209

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MOCS2protein_codingprotein_codingENST00000396954 514385
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0004610.6821257120341257460.000135
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.078810198.81.020.000004821229
Missense in Polyphen2126.5750.79021322
Synonymous0.7103439.70.8570.00000241340
Loss of Function0.79368.490.7073.54e-7120

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.0008380.000832
European (Non-Finnish)0.00007070.0000703
Middle Eastern0.00005440.0000544
South Asian0.0001640.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalytic subunit of the molybdopterin synthase complex, a complex that catalyzes the conversion of precursor Z into molybdopterin. Acts by mediating the incorporation of 2 sulfur atoms from thiocarboxylated MOCS2A into precursor Z to generate a dithiolene group. {ECO:0000255|HAMAP-Rule:MF_03052, ECO:0000269|PubMed:12732628, ECO:0000269|PubMed:15073332}.;
Pathway
Folate biosynthesis - Homo sapiens (human);Sulfur relay system - Homo sapiens (human);Metabolism;Molybdenum cofactor biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;molybdenum cofactor biosynthesis (Consensus)

Recessive Scores

pRec
0.175

Intolerance Scores

loftool
0.860
rvis_EVS
0.53
rvis_percentile_EVS
80.73

Haploinsufficiency Scores

pHI
0.0696
hipred
N
hipred_score
0.253
ghis
0.443

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.141

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mocs2
Phenotype
muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
Mo-molybdopterin cofactor biosynthetic process;molybdopterin cofactor biosynthetic process
Cellular component
nucleus;cytosol;nuclear speck;molybdopterin synthase complex
Molecular function
molybdopterin synthase activity